Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–driven coronavirus disease 2019 (COVID-19) has caused unprecedented human death and has seriously threatened the global economy. Early data suggest a surge in proinflammatory cytokines in patients with severe COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Mohammed, Faridi, Rehan M., Sligl, Wendy, Shabani-Rad, Meer-Taher, Dharmani-Khan, Poonam, Parker, Arabesque, Kalra, Amit, Tripathi, Minal Borkar, Storek, Jan, Cohen Tervaert, Jan Willem, Khan, Faisal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594380/
https://www.ncbi.nlm.nih.gov/pubmed/33075136
http://dx.doi.org/10.1182/bloodadvances.2020002650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594380/
https://www.ncbi.nlm.nih.gov/pubmed/33075136
http://dx.doi.org/10.1182/bloodadvances.2020002650

Ejemplares similares